Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/322
Title: Glucagon test in insulinoma: Is it useful?
Authors: FELICIO, J. S.MARTINS, C. L. L. P.MILEO, K. B.SEMER, M.KALININ, L.NERY, M.MACHADO, M. C. C.LIBERMAN, B.
Citation: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, v.35, n.6, p.570-572, 2012
Abstract: Diagnosis of endogenous hyperinsulinism caused by insulinoma is based on confirmation of hypoglycemia during the symptoms associated to elevated insulin levels. Patients with insulinoma may demonstrate an excessive insulin response and subsequent hypoglycemia after 1 mg of glucagon iv injection. Glucagon test was performed in 11 patients with insulinoma before therapy and in 4 after therapy. Our study suggests that the presence of plasma glucose levels less than 55 mg/dl and below baseline at time 120 min of glucagon test strongly reinforce the diagnosis of insulinoma. (J. Endocrinol. Invest. 35: 570-572, 2012) (C) 2012, Editrice Kurtis
Appears in Collections:Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/51

Files in This Item:
File Description SizeFormat 
art_FELICIO_Glucagon_test_in_insulinoma-Is_it_useful_2012.PDF
  Restricted Access
publishedVersion (English)134.51 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.